Press Releases

Biocartis Launches Liquid Biopsy Idylla™ ctEGFR Mutation Assay

Five Idylla™ Performance Studies to be Presented at ‘European Society for Medical Oncology’ congress

Study on Performance Data of Idylla™ NRAS-BRAF Mutation Assay at 71st AACC Annual Scientific Meeting in Anaheim, CA (US)

Biocartis and Kite Sign Agreement for Development of Assays supporting Kite’s Therapies

Idylla™ MSI Performance Study Selected for Publication at ASCO Conference

Biocartis and Bristol Myers Squibb Sign Collaboration Agreement for MSI Testing with Immuno-Oncology Therapies

Biocartis announces CE-IVD marking of its Idylla™ MSI Test

Biocartis Places Its 1,000th Idylla™ Instrument with Geisinger in US

Biocartis and Nichirei Bioscience Announce Commercialization Collaboration for Japanese Market

Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla™ Oncotype DX Genomic Prostate Score® Test